Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Page logo
Latest News

Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

NEW BRUNSWICK, N.J., Aug. 9, 2022 -- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14th, at the Sheraton New York Hotel in New York. Joaquin Duato, Chief Executive Officer, and Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 11:10 a.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

  • Media Contacts:
    Jake Sargent
    (732) 524-1090

    Investor Contacts:
    Lisa Romanko
    (732) 524-2034

    Sarah Wood
    (732) 524-2617
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue